Cargando…
Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire
OBJECTIVE: SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335352/ https://www.ncbi.nlm.nih.gov/pubmed/35914734 http://dx.doi.org/10.1016/j.gofs.2022.07.004 |
_version_ | 1784759319694147584 |
---|---|
author | Huré, M. Peyronnet, V. Sibiude, J. Cazenave, M.G. Anselem, O. Luton, D. Vauloup-Fellous, C. Deruelle, P. Cordier, A.G. Benachi, A. Mandelbrot, L. Couffignal, C. Pauphilet, V. Vivanti, A.J. Picone, O. |
author_facet | Huré, M. Peyronnet, V. Sibiude, J. Cazenave, M.G. Anselem, O. Luton, D. Vauloup-Fellous, C. Deruelle, P. Cordier, A.G. Benachi, A. Mandelbrot, L. Couffignal, C. Pauphilet, V. Vivanti, A.J. Picone, O. |
author_sort | Huré, M. |
collection | PubMed |
description | OBJECTIVE: SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-19 vaccination and factors associated in women during their pregnancy. MATERIAL AND METHOD: Multicenter cross-sectional survey study conducted from September to December 2021 with online self-questionnaire. All postpartum patients hospitalized in one of the 6 participating maternity hospitals were invited to answer. The questionnaire asked patients about their demographic characteristics, vaccination modalities, vaccine tolerance, and their general perception of vaccination. RESULTS: Of the 371 women who responded, the vaccination rate was 65.7% (IC95% [60.8–70.4]), whom 98.8% entirely during pregnancy. Associated factors with vaccination during pregnancy were older age, higher socio-professional category, and prior information provided by health professionals. Factors that appear to motivate vaccination were personal protection and protection of the newborn. Finally, main factors negatively influencing the vaccination process were the fear of vaccine side effects and the negative perception of vaccines in general. DISCUSSION: Acceptability and information about the vaccine by health professionals is in constant improvement. Information campaigns should be continued to improve the acceptability of vaccination, in light of the accumulating data. |
format | Online Article Text |
id | pubmed-9335352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93353522022-07-29 Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire Huré, M. Peyronnet, V. Sibiude, J. Cazenave, M.G. Anselem, O. Luton, D. Vauloup-Fellous, C. Deruelle, P. Cordier, A.G. Benachi, A. Mandelbrot, L. Couffignal, C. Pauphilet, V. Vivanti, A.J. Picone, O. Gynecol Obstet Fertil Senol Article Original OBJECTIVE: SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-19 vaccination and factors associated in women during their pregnancy. MATERIAL AND METHOD: Multicenter cross-sectional survey study conducted from September to December 2021 with online self-questionnaire. All postpartum patients hospitalized in one of the 6 participating maternity hospitals were invited to answer. The questionnaire asked patients about their demographic characteristics, vaccination modalities, vaccine tolerance, and their general perception of vaccination. RESULTS: Of the 371 women who responded, the vaccination rate was 65.7% (IC95% [60.8–70.4]), whom 98.8% entirely during pregnancy. Associated factors with vaccination during pregnancy were older age, higher socio-professional category, and prior information provided by health professionals. Factors that appear to motivate vaccination were personal protection and protection of the newborn. Finally, main factors negatively influencing the vaccination process were the fear of vaccine side effects and the negative perception of vaccines in general. DISCUSSION: Acceptability and information about the vaccine by health professionals is in constant improvement. Information campaigns should be continued to improve the acceptability of vaccination, in light of the accumulating data. Elsevier Masson SAS. 2022-11 2022-07-29 /pmc/articles/PMC9335352/ /pubmed/35914734 http://dx.doi.org/10.1016/j.gofs.2022.07.004 Text en © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Original Huré, M. Peyronnet, V. Sibiude, J. Cazenave, M.G. Anselem, O. Luton, D. Vauloup-Fellous, C. Deruelle, P. Cordier, A.G. Benachi, A. Mandelbrot, L. Couffignal, C. Pauphilet, V. Vivanti, A.J. Picone, O. Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire |
title | Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire |
title_full | Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire |
title_fullStr | Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire |
title_full_unstemmed | Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire |
title_short | Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire |
title_sort | acceptabilité du vaccin-sars cov-2 chez les femmes enceintes, une enquête transversale par questionnaire |
topic | Article Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335352/ https://www.ncbi.nlm.nih.gov/pubmed/35914734 http://dx.doi.org/10.1016/j.gofs.2022.07.004 |
work_keys_str_mv | AT hurem acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT peyronnetv acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT sibiudej acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT cazenavemg acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT anselemo acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT lutond acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT vauloupfellousc acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT deruellep acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT cordierag acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT benachia acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT mandelbrotl acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT couffignalc acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT pauphiletv acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT vivantiaj acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire AT piconeo acceptabiliteduvaccinsarscov2chezlesfemmesenceintesuneenquetetransversaleparquestionnaire |